Substituted oxazolidinones for combinational therapy
Details for Australian Patent Application No. 2002312982 (hide)
International Classifications
Event Publications
2 January 2003 Complete Application Filed
Priority application(s): 101 29 725.4 20.06.01 DE
19 June 2003 Application Open to Public Inspection
Published as AU-B-2002312982
24 January 2008 Application Accepted
Published as AU-B-2002312982
22 May 2008 Standard Patent Sealed
14 May 2009 Assignment Registered
Bayer HealthCare AG The patent has been assigned to Bayer Schering Pharma Aktiengesellschaft
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002312981-REGULATION OF HUMAN SERINE/ THREONINE PROTEIN KINASE-LIKE ENZYME
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser